To provide a practical approach to pharmacists regarding the safe and effective use of nadofaragene firadenovec. Clinical study data and pharmacist experience in institutional settings. This review ...
The first reporting of real-world data for nadofaragene firadenovec-vncg (Adstiladrin) indicate that the non–muscle invasive bladder cancer (NMIBC) treatment yields positive efficacy and safety ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN ® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of ...
Ferring Pharmaceuticals announced today three abstracts featuring ADSTILADRIN ® (nadofaragene firadenovec-vncg) will be presented at the 2025 American Society of Clinical Oncologists ...